Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
B. Routy +47 more
semanticscholar +1 more source
Developing a Parent-Focused Decision Aid to Promote Child-Inclusive Shared Decision-Making in Pediatric Oral Immunotherapy: Pragmatic Exploratory Feasibility Study. [PDF]
Hayama J +5 more
europepmc +1 more source
Rapid food desensitization associated with omalizumab before oral immunotherapy. [PDF]
Giavina-Bianchi B, Giavina-Bianchi P.
europepmc +1 more source
A case report: Diagnosis and treatment of idiopathic hypertrophic pachymeningitis
We reported a case of idiopathic hypertrophic dura meningitis diagnosed in our hospital. The patient repeatedly suffered from headaches, followed by blurred vision in the right eye. During this period, multiple sclerosis was considered for diagnosis, and it improved after hormone treatment.
Zhong Luo +7 more
wiley +1 more source
Molecular imprinting for neurology: Materials, applications, and limitations
Molecularly imprinted materials: diagnostic, therapeutic and research applications in neurology. Molecularly imprinted materials offer high specificity and affinity for target molecules in neurological applications. This review highlights their synthesis, characterisation, and use in diagnostics, research and therapeutics.
Xiaohan Ma +3 more
wiley +1 more source
The Role of Omalizumab as an Adjunct to Oral Immunotherapy in Pediatric Food Allergy: A Systematic Review. [PDF]
Khidir Mustafa AA +6 more
europepmc +1 more source
[Oral immunotherapy versus parenteral immunotherapy].
A, Romo +4 more
openaire +1 more source
Outcomes and risk factors of hemorrhage in patients with resected brain metastases
What's New? Brain metastases may present with hemorrhage, yet risk factors and clinical outcomes remain unclear. Based on a cohort of 880 patients with resected brain metastases, this study identified tumor volume and primary tumor histology (melanoma and non‐small cell lung cancer) as key predictors of hemorrhage.
Melisa S. Guelen +17 more
wiley +1 more source
What's New? Anti‐angiogenic drugs have shown promising efficacy as a second‐line treatment for advanced gastric cancer. However, it remains unclear how alterations in the tumor microenvironment following first‐line immunotherapy may impact tumor angiogenesis and influence subsequent therapeutic outcomes. This single‐arm study prospectively explored the
Xiaoting Ma +11 more
wiley +1 more source

